•  
  •  
  •  
  •  

2023-09-22 21:12:23

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Regency Ceramics Ltd kickstarts its revival, commences product deliveries in Chennai
  • Cigniti Technologies Recognized as a Leader in Everest Group's Quality Engineering Services PEAK Matrix® Assessment 2023
  • SBI raises Rs. 10,000 crores through 4th infrastructure bond issue
  • Technical Wrap - Sep 22, 2023 - HDFC Securities
  • Federal Bank Hosted a Cricket Extravaganza: ICC Men's Cricket World Cup Trophy Tour Arrived with a Bang!

Keywords Selected:  USFDA

Stock Report

  • USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA
  • Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP, 1%
  • Caplin Steriles gets USFDA approval for Norepinephrine Bitartrate Injection
  • Completion of US FDA Inspection at Unit IV of APL Healthcare Ltd
  • Zydus receives EIR for the formulation manufacturing facility at SEZ 2, Ahmedabad
  • Strides receives tentative USFDA approval for Dolutegravir / Lamivudine / Tenofovir Disproxil Fumurate tablets
  • Zydus receives final approval from the USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day
  • Strides receives tentative USFDA approval for Dolutegravir tablets
  • Bajaj Healthcare Ltd receives EIR from USFDA for API manufacturing facility in Savli
  • Zydus receives EIR for the injectables manufacturing facility at Zydus Biotech Park, Ahmedabad
  • Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension
  • Aurobindo Pharma Ltd updates on US FDA inspection at Unit 3
  • Caplin Steriles receives EIR from US FDA
  • Zydus receives final approval from the USFDA for Erythromycin Tablets USP, 250 mg and 500 mg
  • Zydus receives final approval from the USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg
  • Ajanta Pharma Ltd receives final approval from US FDA for Topiramate Extended Release Capsules
  • Strides receives USFDA approval for Mycophenolate Mofetil for Oral Suspension
  • Unichem Laboratories Ltd receives ANDA approval for Prasugrel Tablets
  • Lupin Receives Approval from U.S. FDA for Pirfenidone Capsules
  • Gland Pharma Limited updates on USFDA Pre-Market Inspection at Pashamylaram Facility
  • Lupin receives approval from U.S. FDA for Pirfenidone Tablets
  • Gland Pharma Limited receives EIR from USFDA for Dundigal Facility
  • Zydus receives final approval from the USFDA for Zinc Sulfate Injection Pharmacy Bulk Package Vials
  • Torrent Pharmaceuticals Ltd's Dahej facility gets EIR from USFDA

Latest Post

  • Regency Ceramics Ltd kickstarts its revival, commences product deliveries in Chennai
  • Cigniti Technologies Recognized as a Leader in Everest Group's Quality Engineering Services PEAK Matrix® Assessment 2023
  • SBI raises Rs. 10,000 crores through 4th infrastructure bond issue
  • Technical Wrap - Sep 22, 2023 - HDFC Securities
  • Federal Bank Hosted a Cricket Extravaganza: ICC Men's Cricket World Cup Trophy Tour Arrived with a Bang!


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2022